Keywords: اوناتومومب; ICER; incremental cost-effectiveness ratio; QALY; quality-adjusted life-year; ITC; indirect treatment comparison; Chronic lymphocytic leukaemia; Obinutuzumab; Chlorambucil; Rituximab; Ofatumumab; Cost-effectiveness; Costs;
مقالات ISI اوناتومومب (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: اوناتومومب; bendamustine; chronic lymphocytic leukemia; economic evaluation; obinutuzumab; ofatumumab; rituximab;
Keywords: اوناتومومب; Alemtuzumab; Ibrutinib; Idelalisib; Obinutuzumab; Ofatumumab; Rituximab;
In situ quantitative bioanalysis of monomethyl auristatin E-conjugated antibody-drug conjugates by flow cytometry
Keywords: اوناتومومب; Antibody-drug conjugates; Ligand-binding assay; Flow cytometry; In situ bioanalysis; Ofatumumab;
An Evidence-based Review of Anti-CD20 Antibody-containing Regimens for the Treatment of Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia, Diffuse Large B-cell Lymphoma, or Follicular Lymphoma
Keywords: اوناتومومب; B-cell lymphoproliferative disorders; Non-Hodgkin lymphoma; Obinutuzumab; Ofatumumab; Rituximab;
Dancing partners at the ball: Rational selection of next generation anti-CD20 antibodies for combination therapy of chronic lymphocytic leukemia in the novel agents era
Keywords: اوناتومومب; Obinutuzumab; Ocaratuzumab; Ofatumumab; Rituximab; Ublituximab; Veltuzumab;
Indirect Treatment Comparisons of Ibrutinib Versus Physician's Choice and Idelalisib Plus Ofatumumab in Patients With Previously Treated Chronic Lymphocytic Leukemia
Keywords: اوناتومومب; chronic lymphocytic leukemia; ibrutinib; idelalisib; ofatumumab; indirect treatment comparison;
Current strategies to create tailored and risk-adapted therapies for CLL patients
Keywords: اوناتومومب; CLL; Maintenance; MRD; Venetoclax (ABT-199); Ibrutinib; Idelalisib (CAL-101); Obinutuzumab (GA101); Ofatumumab;
Real-time analysis of the detailed sequence of cellular events in mAb-mediated complement-dependent cytotoxicity of B-cell lines and of chronic lymphocytic leukemia B-cells
Keywords: اوناتومومب; Al; Alexa Fluor; CLL; chronic lymphocytic leukemia; CDC; complement-dependent cytotoxicity; GMI; geometrical mean intensity; HI; heat inactivated; Hx; hexamerization enchanced; MAC; membrane attack complex; MESF; molecules of equivalent soluble fluorochro
Ofatumumab in Refractory Chronic Lymphocytic Leukemia: Experience Through the French Early Access Program
Keywords: اوناتومومب; CD20; CLL; Ofatumumab; Relapsed/refractory; Temporary use authorization
Ofatumumab in Combination with Glucocorticoids for Primary Therapy of Chronic Graft-versus-Host Disease: Phase I Trial Results
Keywords: اوناتومومب; Chronic graft-versus-host disease; Primary therapy; Prednisone; Ofatumumab
Pro-apoptotic effect of an anti-CD37 scFv-Fc fusion protein, in combination with the anti-CD20 antibody, ofatumumab, on tumour cells from B-cell malignancies
Keywords: اوناتومومب; SMIP-016; TRU-016; Ofatumumab; Chronic lymphocytic leukaemia; B-cell malignancies;
False-positive immunogenicity responses are caused by CD20+ B cell membrane fragments in an anti-ofatumumab antibody bridging assay
Keywords: اوناتومومب; CLL; chronic lymphocytic leukemia; CMFs; cell membrane fragments; ADA; anti-drug antibody; ECL; electrochemiluminescent; RTX; rituximab; Ofa; Ofatumumab; MVs; microvesicles; MSD; Meso-Scale Discovery; NC; negative control; PC; positive control; Immunogeni
PrzeciwciaÅa monoklonalne w leczeniu przewlekÅej biaÅaczki limfocytowej
Keywords: اوناتومومب; przeciwciaÅa monoklonalne; rytuksymab; alemtuzumab; ofatumumab; obinutuzumab; GA-101; lumiliksymab; TRU-016; Epratuzumab; moxetumomab pasudotox; apolizumab; lucatumumab; SGN-40; Monoclonal antibodies; Rituximab; Alemtuzumab; Ofatumumab; Obinutuzumab; GA-
Standards for the Treatment of Relapsed Chronic Lymphocytic Leukemia: A Case-Based Study
Keywords: اوناتومومب; AlloHSCT; Bendamustine; Flavopiridol; Fludarabine-refractory disease; Lenalidomide; Rituximab; Ofatumumab
Chronic Lymphocytic Leukemia: New Concepts for Future Therapy
Keywords: اوناتومومب; Alemtuzumab; Bendamustine; Flavopiridol; Lenalidomide; Ofatumumab
Monoclonal antibody therapy of chronic lymphocytic leukaemia
Keywords: اوناتومومب; monoclonal antibody; rituximab; alemtuzumab; ofatumumab; chemoimmunotherapy
Structure of the Fab fragment of therapeutic antibody Ofatumumab provides insights into the recognition mechanism with CD20
Keywords: اوناتومومب; mAb, monoclonal antibody; CDR, complementarity determining regionCD20; Ofatumumab; 2F2; Therapeutic antibody; Crystal structure